1. Home
  2. EKSO vs YHC Comparison

EKSO vs YHC Comparison

Compare EKSO & YHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EKSO
  • YHC
  • Stock Information
  • Founded
  • EKSO 2005
  • YHC 2021
  • Country
  • EKSO United States
  • YHC United States
  • Employees
  • EKSO N/A
  • YHC N/A
  • Industry
  • EKSO Medical/Dental Instruments
  • YHC Beverages (Production/Distribution)
  • Sector
  • EKSO Health Care
  • YHC Consumer Staples
  • Exchange
  • EKSO Nasdaq
  • YHC Nasdaq
  • Market Cap
  • EKSO 13.4M
  • YHC 12.3M
  • IPO Year
  • EKSO N/A
  • YHC N/A
  • Fundamental
  • Price
  • EKSO $0.54
  • YHC $1.03
  • Analyst Decision
  • EKSO Strong Buy
  • YHC
  • Analyst Count
  • EKSO 2
  • YHC 0
  • Target Price
  • EKSO $5.50
  • YHC N/A
  • AVG Volume (30 Days)
  • EKSO 2.9M
  • YHC 102.7K
  • Earning Date
  • EKSO 03-03-2025
  • YHC 03-31-2025
  • Dividend Yield
  • EKSO N/A
  • YHC N/A
  • EPS Growth
  • EKSO N/A
  • YHC N/A
  • EPS
  • EKSO N/A
  • YHC N/A
  • Revenue
  • EKSO $17,682,000.00
  • YHC $2,272,001.00
  • Revenue This Year
  • EKSO N/A
  • YHC $120.06
  • Revenue Next Year
  • EKSO $32.74
  • YHC $72.42
  • P/E Ratio
  • EKSO N/A
  • YHC N/A
  • Revenue Growth
  • EKSO 4.12
  • YHC 158.05
  • 52 Week Low
  • EKSO $0.47
  • YHC $0.40
  • 52 Week High
  • EKSO $2.32
  • YHC $2.83
  • Technical
  • Relative Strength Index (RSI)
  • EKSO 36.46
  • YHC N/A
  • Support Level
  • EKSO $0.47
  • YHC N/A
  • Resistance Level
  • EKSO $0.67
  • YHC N/A
  • Average True Range (ATR)
  • EKSO 0.06
  • YHC 0.00
  • MACD
  • EKSO -0.01
  • YHC 0.00
  • Stochastic Oscillator
  • EKSO 22.90
  • YHC 0.00

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.

Share on Social Networks: